Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options

Fig. 3

Clinical course. The graph shows the significant drop of Epstein-Barr viral load in the peripheral blood after initiation of chemotherapy. After 3 cycles of CHOP chemotherapy PCR for EBV-DNA was negative. In addition, PET-CT scan revealed no glucose-uptake of initial positive lesions. CHOP: cyclophosphamide, doxorubicin, vincristin and prednisolon

Back to article page